Keybank National Association Exact Sciences Corp Transaction History

Keybank National Association

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 08, 2021	SELL	$90.24 - $124.05 $151,783 - $208,652	-1,682 Closed	0 $0
Q2 2021 Aug 12, 2021	SELL	$93.66 - $139.27 $402,644 - $598,721	-4,299 Reduced 71.88%	1,682 $209,000
Q1 2021 May 07, 2021	BUY	$116.57 - $155.01 $509,760 - $677,858	4,373 Added 271.95%	5,981 $788,000
Q4 2020 Feb 09, 2021	BUY	$99.61 - $142.12 $160,172 - $228,528	1,608 New	1,608 $213,000
Q4 2018 Jan 30, 2019	SELL	$56.04 - $82.66 $475,891 - $701,948	-8,492 Closed	0 $0
Q3 2018 Nov 08, 2018	SELL	$48.29 - $80.6 $223,003 - $372,210	-4,618 Reduced 35.23%	8,492 $670,000
Q2 2018 Aug 08, 2018	BUY	$37.84 - $69.96 $3,973 - $7,345	105 Added 0.81%	13,110 $784,000
Q1 2018 May 15, 2018	BUY	$39.82 - $57.53 $170,549 - $246,400	4,283 Added 49.11%	13,005 $524,000
Q4 2017 Feb 08, 2018	SELL	$46.49 - $60.51 $138,214 - $179,896	-2,973 Reduced 25.42%	8,722 $458,000
Q3 2017 Nov 02, 2017	SELL	$37.05 - $47.12 $244,455 - $310,897	-6,598 Reduced 36.07%	11,695 $551,000
Q2 2017 May 14, 2018	SELL	N/A	-16,162 Reduced 46.91%	18,293 $647,000
Q1 2017 May 14, 2018	SELL	N/A	-1,304 Reduced 3.65%	34,455 $814,000
Q4 2016 May 14, 2018	BUY	N/A	35,759	35,759 $478,000

673

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.3B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Keybank National Association, based on Form 13F filings with the SEC.

Stay updated on Keybank National Association with notifications on news.